No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
TROW240816C125000
- 0.75
- +0.21+38.89%
15min DelayClose Jul 23 14:06 ET
0.75High0.45Low
0.45Open0.54Pre Close30 Volume641 Open Interest125.00Strike Price1.95KTurnover24.81%IV7.47%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type0.1727Delta0.0341Gamma173.35Leverage Ratio-0.0421Theta0.0130Rho29.93Eff Leverage0.0772Vega
Intraday
- 5D
- Daily
News
Express News | JP Morgan Maintains Underweight on T. Rowe Price Gr, Raises Price Target to $107
Decent Equity Market to Aid T. Rowe Price (TROW) in Q2 Earnings
Morgan Stanley Maintains T. Rowe Price(TROW.US) With Hold Rating, Maintains Target Price $125
Express News | T Rowe Price Group Inc : JP Morgan Raises Target Price to $107 From $102
The Best U.S. City for Retirement Healthcare
Tesla, AT&T, Alphabet, Chipotle, Visa, and More Stocks to Watch This Week
Comments
Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
$Datadog(DDOG.US$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies(ACLS.US$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
$Datadog(DDOG.US$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies(ACLS.US$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
6
OHA and TPO's partnership is strategic for STV's growth, focusing on geographic and service line expansion. OHA's industry experience and financing solutions are highly valued.
1
OHA believes that Greenway Health is well-positioned for scalable and profitable growth. The firm also expects the financing opportunity to continue to grow in 2024 for high-quality borrowers to address near-term maturities.
1
Despite the slump in earnings, T. Rowe Price's P/E ratio hints at hopeful investors, contrasting analysts' pessimism. The ongoing decline in earnings may affect future share price.
CEO Rob Sharps commends Eric Veiel's promotion, acknowledging his innovative thinking, commitment to high-standard investments, diversity and global perspective.
Read more